Defiance Daily Target 2x Long LLY ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LLYX and other ETFs, options, and stocks.

About LLYX

LLYX seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. 

Category
Trading--Leveraged Equity
CategoryTrading--Leveraged Equity
Number of holdings
12
Number of holdings12
Inception Date
Aug 8, 2024
Inception DateAug 8, 2024

LLYX Key Statistics

AUM
48.25M
AUM48.25M
Price-Earnings ratio
Price-Earnings ratio
30-Day yield
-0.55
30-Day yield-0.55
Average volume
472.53K
Average volume472.53K
High today
$28.68
High today$28.68
Low today
$27.53
Low today$27.53
Open price
$28.24
Open price$28.24
Volume
124.60K
Volume124.60K
52 Week high
$29.95
52 Week high$29.95
52 Week low
$9.67
52 Week low$9.67
Expense ratio
1.32
Expense ratio1.32

Stock Snapshot

With a market cap of 47.46M, Defiance Daily Target 2x Long LLY ETF(LLYX) trades at $28.08.

During the trading session on 2026-08-11, Defiance Daily Target 2x Long LLY ETF(LLYX) shares reached a daily high of $28.68 and a low of $27.53. At a current price of $28.08, the stock is +2.0% higher than the low and still -2.1% under the high.

Trading volume for Defiance Daily Target 2x Long LLY ETF(LLYX) stock has reached 124.6K, versus its average volume of 472.53K.

The stock's 52-week range extends from a low of $9.67 to a high of $29.95.

The stock's 52-week range extends from a low of $9.67 to a high of $29.95.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.